Online Ahead of Print: January 14, 2015The pathogenesis of nonalcoholic steatohepatitis is primarily an immune-driven disease and a known factor associated with treatment failure of chronic hepatitis C with interferon (IFN) and ribavirin. We studied the hepatocyte response in a model of steatosis at the transcriptome level and the antiviral action of IFN against hepatitis C virus (HCV) in this setting. In this study, we have shown that lipid loading (oleic acid and palmitic acid, OA:PA) of Huh-7 cells leads to increased expression of classical interferon-stimulated genes (ISGs) and NF-κβ-dependent pro-inflammatory genes. A selective blocker of Toll-like receptor (TLR)2 signaling suppressed NF-κβ promoter activity by OA:PA, suggesting that f...
Hepatitis C virus (HCV) is a lipid-enveloped virion particle that causes infection to the liver, and...
BACKGROUND & AIMS: Hepatic steatosis is frequent in chronic hepatitis C. Several mechanisms migh...
Overweight and obesity are major risk factors for development of non-alcoholic fatty liver disease (...
Hepatitis C Virus (HCV) is a significant global health issue that leads to the development of chroni...
Background Hepatic steatosis is a risk factor for both liver disease progression and an impaired re-...
Hepatitis C virus (HCV) infects millions of people worldwide and is one of the leading causes of liv...
Hepatitis C virus (HCV) is a successful pathogen on the grounds that it exploits its host's metaboli...
Invasion by infectious pathogens can elicit a range of cytokine responses from host cells. These cyt...
Hepatic steatosis is a risk factor for both liver disease progression and an impaired response to in...
[[abstract]]HCV infection can lead to chronic infectious hepatitis disease with serious sequelae. In...
BACKGROUND: Hepatitis C virus (HCV) infection and metabolic diseases including nonalcoholic steatohe...
Background/Aims: Signal transducer and activator of transcription (STAT) pathway plays an important ...
Peginterferon lambda-1a (Lambda), a type III interferon (IFN), acts through a unique recep-tor compl...
BACKGROUND: Hepatitis C virus (HCV) infection and metabolic diseases including nonalcoholic steatohe...
Background HCV replication in persistently infected cell culture remains resistant to IFN-α/RBV comb...
Hepatitis C virus (HCV) is a lipid-enveloped virion particle that causes infection to the liver, and...
BACKGROUND & AIMS: Hepatic steatosis is frequent in chronic hepatitis C. Several mechanisms migh...
Overweight and obesity are major risk factors for development of non-alcoholic fatty liver disease (...
Hepatitis C Virus (HCV) is a significant global health issue that leads to the development of chroni...
Background Hepatic steatosis is a risk factor for both liver disease progression and an impaired re-...
Hepatitis C virus (HCV) infects millions of people worldwide and is one of the leading causes of liv...
Hepatitis C virus (HCV) is a successful pathogen on the grounds that it exploits its host's metaboli...
Invasion by infectious pathogens can elicit a range of cytokine responses from host cells. These cyt...
Hepatic steatosis is a risk factor for both liver disease progression and an impaired response to in...
[[abstract]]HCV infection can lead to chronic infectious hepatitis disease with serious sequelae. In...
BACKGROUND: Hepatitis C virus (HCV) infection and metabolic diseases including nonalcoholic steatohe...
Background/Aims: Signal transducer and activator of transcription (STAT) pathway plays an important ...
Peginterferon lambda-1a (Lambda), a type III interferon (IFN), acts through a unique recep-tor compl...
BACKGROUND: Hepatitis C virus (HCV) infection and metabolic diseases including nonalcoholic steatohe...
Background HCV replication in persistently infected cell culture remains resistant to IFN-α/RBV comb...
Hepatitis C virus (HCV) is a lipid-enveloped virion particle that causes infection to the liver, and...
BACKGROUND & AIMS: Hepatic steatosis is frequent in chronic hepatitis C. Several mechanisms migh...
Overweight and obesity are major risk factors for development of non-alcoholic fatty liver disease (...